Concepedia

Author

Brian H. Kushner

Memorial Sloan Kettering Cancer CenterORCID

Also Known As

B H Kushner, B KUSHNER, B Kushner, B. H. Kushner, B. Kushner, B.H Kushner, B.H. Kushner, Brian H Kushner, Brian H. Kushner, Brian Kushner

276

Publications

9.6K

Citations

54

H-Index

86

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center
BH

About

Brian H. Kushner is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

45

2.7K

2

Health Sciences

15

16

1.1K

3

Cell Biology

6

6

311

4

Allergy

1

1

39

5

Biochemistry

1

1

37

Brian H. Kushner

×

129

Publications

8.7K

Citations

53

H-Index

YearCitations

Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.

William L. Gerald, Marc Ladanyi, Enrique de Álava,

Journal of Clinical Oncology

1998

417

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.

Brian H. Kushner, Michael P. LaQuaglia, Norma Wollner,

Journal of Clinical Oncology

1996

369

Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-<i>Cis</i>-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

Nai‐Kong V. Cheung, Irene Y. Cheung, Brian H. Kushner,

Journal of Clinical Oncology

2012

254

Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma

Kim Kramer, Brian H. Kushner, Shakeel Modak,

Journal of Neuro-Oncology

2009

238

Neuroblastoma: a disease requiring a multitude of imaging studies.

Brian H. Kushner

PubMed

2004

212

Phase II Trial of the Anti-G<sub>D2</sub>Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma

Brian H. Kushner, Kim Kramer, Nai‐Kong V. Cheung

Journal of Clinical Oncology

2001

204

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.

Nai‐Kong V. Cheung, Brian H. Kushner, Irene Y. Cheung,

Journal of Clinical Oncology

1998

197

Extracranial primitive neuroectodermal tumors. The memorial sloan-kettering cancer center experience

Brian H. Kushner, Steven I. Hajdu, Subhash C. Gulati,

Cancer

1991

188

Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults

E. Anders Kolb, Brian H. Kushner, Richard Görlick,

Journal of Clinical Oncology

2003

179

The impact of gross total resection on local control and survival in high-risk neuroblastoma

Michael P. LaQuaglia, Brian H. Kushner, Wendy Su,

Journal of Pediatric Surgery

2004

167

Page 1